Paper40565795
Treating IgA Nephropathy: Looking at the Future Without Forgetting the Past.
Coppo R. J Clin Med, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Treating IgA Nephropathy: Looking at the Future Without Forgetting the Past. Papers, record 40565795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40565795
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40082161 | IgAN Across the Age Spectrum: The Pediatric Perspective. | Semin Nephrol | 2024 | https://conductscience.org/library/papers/40082161 | PubMed |
| 2 | 32450154 | After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy. | Kidney Int | 2020 | https://conductscience.org/library/papers/32450154 | PubMed |
| 3 | 36938094 | Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria. | Kidney Int Rep | 2023 | https://conductscience.org/library/papers/36938094 | PubMed |
| 4 | 28215945 | Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial. | Am J Kidney Dis | 2017 | https://conductscience.org/library/papers/28215945 | PubMed |
| 5 | 28763548 | Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. | JAMA | 2017 | https://conductscience.org/library/papers/28763548 | PubMed |
| 6 | 34556300 | Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. | Kidney Int | 2021 | https://conductscience.org/library/papers/34556300 | PubMed |
| 7 | 4601708 | IgA nephropathy. | Am J Pathol | 1974 | https://conductscience.org/library/papers/4601708 | PubMed |
| 8 | 39369368 | The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort. | J Nephrol | 2025 | https://conductscience.org/library/papers/39369368 | PubMed |
| 9 | 37591292 | Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial. | Lancet | 2023 | https://conductscience.org/library/papers/37591292 | PubMed |
| 10 | 37914086 | Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy. | Kidney Int | 2024 | https://conductscience.org/library/papers/37914086 | PubMed |
| 11 | 38552841 | A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy. | Kidney Int | 2024 | https://conductscience.org/library/papers/38552841 | PubMed |
| 12 | 39455063 | Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial. | J Am Soc Nephrol | 2025 | https://conductscience.org/library/papers/39455063 | PubMed |
| 13 | 21949093 | The pathophysiology of IgA nephropathy. | J Am Soc Nephrol | 2011 | https://conductscience.org/library/papers/21949093 | PubMed |
| 14 | 33123355 | Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy. | Clin Kidney J | 2020 | https://conductscience.org/library/papers/33123355 | PubMed |
| 15 | 10093981 | Corticosteroids in IgA nephropathy: a randomised controlled trial. | Lancet | 1999 | https://conductscience.org/library/papers/10093981 | PubMed |
| 16 | 17067945 | Normal structure, function, and histology of mucosa-associated lymphoid tissue. | Toxicol Pathol | 2006 | https://conductscience.org/library/papers/17067945 | PubMed |
| 17 | 26986150 | Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/26986150 | PubMed |
| 18 | 34642783 | The mucosal immune system and IgA nephropathy. | Semin Immunopathol | 2021 | https://conductscience.org/library/papers/34642783 | PubMed |
| 19 | 37931634 | Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial. | Lancet | 2023 | https://conductscience.org/library/papers/37931634 | PubMed |
| 20 | 39460694 | Atrasentan in Patients with IgA Nephropathy. | N Engl J Med | 2025 | https://conductscience.org/library/papers/39460694 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941618 | Association of the Red Blood Cell Distribution Width-to-Albumin Ratio with Renal Outcomes in Chinese Patients with IgA Nephropathy. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941618 | PubMed |
| 42811306 | Targeted-release Budesonide (Nefecon) versus systemic glucocorticoids for IgA nephropathy: a placebo-anchored indirect treatment comparison of randomized controlled trials. | BMC Nephrol | 2026 | https://conductscience.org/library/papers/42811306 | PubMed |
| 42292268 | Effect of SGLT2 inhibitors on microscopic hematuria in IgA nephropathy: a review from the perspective of disease activity biomarkers. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42292268 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD79A | 973 | PubTator's text mining | https://conductscience.org/library/genes/973 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40565795
GET https://conductscience.org/api/papers/v1/40565795/references?page=2